Month: <span>November 2023</span>

Home / 2023 / November
Post

Bad Blood: Could Brain Bleeds Be Contagious?

F. Perry Wilson, MD, MSCEDISCLOSURES Welcome to Impact Factor, your weekly dose of commentary on a new medical study. I’m Dr F. Perry Wilson of the Yale School of Medicine. How do you tell if a condition is caused by an infection? It seems like an obvious question, right? In the post–van Leeuwenhoek era we...

Post

AHA Reviews Impact of Aggressive LDL Lowering on the Brain

Megan Brooks A newly published scientific statement from the American Heart Association (AHA) focuses on the impact of aggressive low-density lipoprotein cholesterol (LDL-C) lowering on the risk for dementia and hemorrhagic stroke. “The brain is the body’s most cholesterol-rich organ, and some have questioned whether aggressive LDL-C lowering induces abnormal structural and functional changes,” the...

Post

MOLECULAR ‘WARHEAD’ DESTROYS LYME DISEASE BACTERIA

NOVEMBER 7TH, 2023POSTED BY SARAH AVERY-DUKE This transport mechanism gets internalized in the bacterium and brings in a molecule that causes what we’ve described as a berserker reaction—a programmed death response,” says Timothy Haystead. “It wipes out the bacteria—sterilizes the culture with a single dose of light.” (Credit: Getty Images) Using a technique that has shown...

Post

CAR-T cell therapy leads to long-term remission in lupus while maintaining vaccine response

by American College of Rheumatology Credit: CC0 Public Domain New research at ACR Convergence 2023, the American College of Rheumatology’s annual meeting, demonstrates that CAR-T cell therapy could lead to sustained suppression of autoantibodies in treatment-resistant lupus while maintaining a robust response to vaccines. Systemic lupus erythematosus (SLE, lupus) is a complex autoimmune disease marked by...

Post

Study shows saliva gland abnormalities in Sjögren’s worsens over time

by American College of Rheumatology Credit: CC0 Public Domain New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that ultrasound-detected salivary gland abnormalities in primary Sjögren’s become more severe over time and that the slow-to-progress disease likely starts long before it is first detected. Sjögren’s disease also known as Primary...

Post

New monoclonal antibodies targeting ACE2 receptor could treat the next waves of SARS-CoV-2

by Justin Jackson , Medical Xpress Inhibition of authentic SARS-CoV-2 infection by human anti-hACE2 mAbs. a,b, Anti-hACE2 mAbs (2G7A1, 05H02, 05B04 and the hybrid antibody 05B04LC/05D06HC) were serially diluted and incubated with Vero E6 and Huh-7.5 target cells (a) or Vero E6 target cells only (b). Thereafter, cells were infected with authentic SARS-CoV-2 (WA1/2020) (a...

PET scans may predict Parkinson’s disease and Lewy body dementia in at-risk individuals
Post

PET scans may predict Parkinson’s disease and Lewy body dementia in at-risk individuals

by Erin Bryant, National Institutes of Health Heart and brain PET scans from a study participant who developed Parkinson’s disease support a “body first” progression. The top pair of PET scans image show low 18F-dopamine-derived radioactivity in the heart (right, with 13N-ammonia PET scan on left). Later, brain scans showed a loss of dopamine-producing neurons and...

Post

Positive antiphospholipid antibodies raises cardiovascular disease risk in patients with systemic lupus erythematosus

by American College of Rheumatology Micrograph of a heart with fibrosis (yellow) and amyloidosis (brown). Movat’s stain. Credit: Nephron/Wikipedia New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, describes a link between positive antiphospholipid antibodies and an increased risk of future cardiovascular disease in patients with systemic lupus erythematosus (SLE). Antiphospholipid...

Post

Researchers identify incidence and risk factors for new-onset interstitial lung disease in systemic sclerosis

by American College of Rheumatology Credit: Pixabay/CC0 Public Domain New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, reports the incidence and risk factors for new-onset interstitial lung disease (ILD) in previously ILD-negative systemic sclerosis patients. Interstitial lung disease is a common complication and cause of death in systemic sclerosis (SSc,...

Post

Researchers say AI model accurately identifies, predicts joint damage in hand X-rays

by American College of Rheumatology Credit: Pixabay/CC0 Public Domain New research at ACR Convergence 2023, the American College of Rheumatology’s (ACR) annual meeting, shows that a deep learning system could accurately identify and predict joint space narrowing and erosions in hand radiographs of patients with rheumatoid arthritis (RA). Radiographs are the most commonly used imaging technique...